Mapping in vivo tumor oxygenation within viable tumor by 19F-MRI and multispectral analysis

Neoplasia (United States)

Volumn 15, Issue 11, 2013, Pages 1241-1250

  Shi, Yunzhou ^a   Oeh, Jason ^a   Eastham Anderson, Jeffrey ^a   Yee, Sharon ^a   Finkle, David ^a   Peale, Franklin V ^a   Ross, Jed ^a   Hedehus, Maj ^a   van Bruggen, Nicholas ^a   Venook, Rayna ^a   Ross, Sarajane ^a   Sampath, Deepak ^a   Carano, Richard A D ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; APITOLISIB; B20.4.1.1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FLUORINE NUCLEAR MAGNETIC RESONANCE; HISTOLOGY; HYPOXIA; MOUSE; MULTISPECTRAL ANALYSIS; NONHUMAN; OXYGEN SATURATION; OXYGEN TENSION; OXYGENATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REPRODUCIBILITY; SINGLE DRUG DOSE; SPECTROSCOPY; TUMOR OXYGENATION; VALIDATION STUDY;

ANIMALS; CELL HYPOXIA; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; FEMALE; HETEROGRAFTS; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; MICE, NUDE; OXYGEN; PHOSPHATIDYLINOSITOL 3-KINASES; TOR SERINE-THREONINE KINASES; TUMOR MICROENVIRONMENT; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84888426336     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.131468     Document Type: Article

References (36)

1. Horsman MR, Mortensen LS, Petersen JB, Busk M, and Overgaard J (2012). Imaging hypoxia to improve radiotherapy outcome. Nat Rev Clin Oncol 9, 674-687.
2. Wilson WR and Hay MP (2011). Targeting hypoxia in cancer therapy. Nat Rev Cancer 11, 393-410.
3. Mason RP, Zhao D, Pacheco-Torres J, Cui W, Kodibagkar VD, Gulaka PK, Hao G, Thorpe P, Hahn EV, and Peschke P (2010). Multimodality imaging of hypoxia in preclinical settings. Q J Nucl Med Mol Imaging 54, 259-280.
4. Dardzinski BJ and Sotak CH (1994). Rapid tissue oxygen tension mapping using 19F inversion-recovery echo-planar imaging of perfluoro-15-crown-5-ether. Magn Reson Med 32, 88-97.
5. Hunjan S, Zhao DW, Constantinescu A, Hahn EW, Antich PP, and Mason RP (2001). Tumor oximetry: demonstration of an enhanced dynamic mapping procedure using fluorine-19 echo planar magnetic resonance imaging in the Dunning prostate R3327-AT1 rat tumor. Int J Radiat Oncol Biol Phys 49, 1097-1108.
6. Jordan BF, Cron GO, and Gallez B (2009). Rapid monitoring of oxygenation by 19F magnetic resonance imaging: simultaneous comparison with fluorescence quenching. Magn Reson Med 61, 634-638.
7. Kadayakkara DKK, Janjic JM, Pusateri LK, Young W-B, and Ahrens ET (2010). In vivo observation of intracellular oximetry in perfluorocarbon-labeled glioma cells and chemotherapeutic response in the CNS using fluorine-19 MRI. Magn Reson Med 64, 1252-1259.
8. Kodibagkar VD, Cui W, Merritt ME, and Mason RP (2006). Novel 1H NMR approach to quantitative tissue oximetry using hexamethyldisiloxane. Magn Reson Med 55, 743-748.
9. Jordan BF, Magat J, Colliez F, Ozel E, Fruytier A-C, Marchand V, Mignion L, Bouzin C, Cani PD, Vandeputte C, et al. (2013). Mapping of oxygen by imaging lipids relaxation enhancement: a potential sensitive endogenous MRI contrast to map variations in tissue oxygenation. Magn Reson Med 70, 732-744.
10. Yu JX, Kodibagkar VD, Cui WN, and Mason RP (2005). 19F: a versatile reporter for non-invasive physiology and pharmacology using magnetic resonance. Curr Med Chem 12, 819-848.
11. Rapisarda A and Melillo G (2012). Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia. Nat Rev Clin Oncol 9, 378-390.
12. Carano RAD, Ross AL, Ross J, Williams SP, Koeppen H, Schwall RH, and Van Bruggen N (2004). Quantification of tumor tissue populations by multispectral analysis. Magn Reson Med 51, 542-551.
13. Conley SJ, Gheordunescu E, Kakarala P, Newman B, Korkaya H, Heath AN, Clouthier SG, and Wicha MS (2012). Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia. Proc Natl Acad Sci USA 109, 2784-2789.
14. Lee CG, Heijn M, di Tomaso E, Griffon-Etienne G, Ancukiewicz M, Koike C, Park KR, Ferrara N, Jain RK, Suit HD, et al. (2000). Anti-vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Cancer Res 60, 5565-5570.
15. Mehta S, Hughes NP, Buffa FM, Li SP, Adams RF, Adwani A, Taylor NJ, Levitt NC, Padhani AR, Makris A, et al. (2011). Assessing early therapeutic response to bevacizumab in primary breast cancer using magnetic resonance imaging and gene expression profiles. J Natl Cancer Inst Monogr 43, 71-74.
16. Rapisarda A, Hollingshead M, Uranchimeg B, Bonomi CA, Borgel SD, Carter JP, Gehrs B, Raffeld M, Kinders RJ, Parchment R, et al. (2009). Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition. Mol Cancer Ther 8, 1867-1877.
17. Sampath D, Oeh JR, Wyatt SK, Cao TC, Koeppen H, Eastham-Anderson J, Robillard L, Ho CC, Ross J, Zhuang G, et al. (2013). Multimodal microvascular imaging reveals that selective inhibition of class I PI3K is sufficient to induce an antivascular response. Neoplasia 15, 694-711.
18. Genentech (2009). A Study Evaluating GDC-0980 Administered Once Weekly in Patients with Refractory Solid Tumors or Non-Hodgkin's Lymphoma. NCT00854126. The United States National Institutes of Health, available at http://clinicaltrials.gov/.
19. Fan XB, River JN, Muresan AS, Popescu C, Zamora M, Culp RM, and Karczmar GS (2006). MRI of perfluorocarbon emulsion kinetics in rodent mammary tumours. Phys Med Biol 51, 211-220.
20. Berry LR, Barck KH, Go MA, Ross J, Wu X, Williams SP, Gogineni A, Cole MJ, Van Bruggen N, Fuh G, et al. (2008). Quantification of viable tumor microvascular characteristics by multispectral analysis. Magn Reson Med 60, 64-72.
21. Ungersma SE, Pacheco G, Ho C, Yee SF, Ross J, van Bruggen N, Peale FV Jr, Ross S, and Carano RAD (2010). Vessel imaging with viable tumor analysis for quantification of tumor angiogenesis. Magn Reson Med 63, 1637-1647.
22. Gross MW, Karbach U, Groebe K, Franko AJ, and Muellerklieser W (1995). Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density in multicellular spheroids. Int J Cancer 61, 567-573.
23. Wang X, Wang T, and Bu J (2011). Color image segmentation using pixel wise support vector machine classification. Pattern Recogn 44, 777-787.
24. Hernandez MIQ (2004). Genetic Programming applied to Morphological Image Processing. PhD thesis, School of Computer Science, University of Birmingham.
25. Mignion L, Magat J, Schakman O, Marbaix E, Gallez B, and Jordan BF (2013). Hexafluorobenzene in comparison with perfluoro-15-crown-5-ether for repeated monitoring of oxygenation using 19F MRI in a mouse model. Magn Reson Med 69, 248-254.
26. Zhao D, Ran S, Constantinescu A, Hahn EW, and Mason RP (2003). Tumor oxygen dynamics: correlation of in vivo MRI with histological findings. Neoplasia 5, 308-318.
27. Zhao DW, Constantinescu A, Hahn EW, and Mason RP (2002). Differential oxygen dynamics in two diverse Dunning prostate R3327 rat tumor sublines (MAT-Lu and HI) with respect to growth and respiratory challenge. Int J Radiat Oncol Biol Phys 53, 744-756.
28. Mason RP, Hunjan S, Le D, Constantinescu A, Barker BR, Wong PS, Peschke P, Hahn EW, and Antich PP (1998). Regional tumor oxygen tension: fluorine echo planar imaging of hexafluorobenzene reveals heterogeneity of dynamics. Int J Radiat Oncol Biol Phys 42, 747-750.
29. Van der Sanden BPJ, Heerschap A, Simonetti AW, Rijken PFJW, Peters HPW, Stuben G, and van der Kogel AJ (1999). Characterization and validation of noninvasive oxygen tension measurements in human glioma xenografts by 19F-MR relaxometry. Int J Radiat Oncol Biol Phys 44, 649-658.
30. Magat J, Jordan BF, Cron GO, and Gallez B (2010). Noninvasive mapping of spontaneous fluctuations in tumor oxygenation using 19F MRI. Med Phys 37, 5434-5441.
31. Baudelet C, Ansiaux R, Jordan BF, Havaux X, Macq B, and Gallez B (2004). Physiological noise in murine solid tumours using T2*-weighted gradient-echo imaging: a marker of tumour acute hypoxia? Phys Med Biol 49, 3389-3411.
32. Dings RPM, Loren M, Heun H, McNiel E, Griffioen AW, Mayo KH, and Griffin RJ (2007). Scheduling of radiation with angiogenesis inhibitors anginex and avastin improves therapeutic outcome via vessel normalization. Clin Cancer Res 13, 3395-3402.
33. Myers AL, Williams RF, Ng CY, Hartwich JE, and Davidoff AM (2011). Bevacizumab-induced tumor vessel remodeling in rhabdomyosarcoma xenografts increases the effectiveness of adjuvant ionizing radiation. J Pediatr Surg 45, 1080-1085.
34. Jain RK (2005). Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307, 58-62.
35. Liang WC, Wu XM, Peale FV, Lee CV, Meng G, Gutierrez J, Fu L, Malik AK, Gerber HP, Ferrara N, et al. (2006). Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF. J Biol Chem 281, 951-961.
36. Jiang L, Greenwood TR, Artemov D, Raman V, Winnard PT Jr, Heeren RMA, Bhujwalla ZM, and Glunde K (2012). Localized hypoxia results in spatially heterogeneous metabolic signatures in breast tumor models. Neoplasia 14, 732-741.